Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3591 studies found for:    Open Studies | "Carcinoma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Intervention: Drug: MLN0128
2 Recruiting Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Laparoscopic liver resection;   Procedure: Open liver resection
3 Not yet recruiting Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma
Condition: Hepatic Carcinoma
Intervention:
4 Recruiting 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: 18F-FluoroethylCholine PET
5 Recruiting Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: The imaging biomarkers determined by MR-PET
6 Not yet recruiting Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Drug: TAK-228
7 Recruiting Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Pembrolizumab;   Procedure: Peripheral Blood Sample (optional);   Genetic: Tumor Tissue Collection (optional)
8 Recruiting Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib
9 Recruiting Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Sorafenib
10 Recruiting Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: liver Perfusion MRI
11 Not yet recruiting A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA
Condition: Hepatocellular Carcinoma
Intervention: Biological: CIK Cell
12 Recruiting Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Procedure: ILAD
13 Recruiting Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Condition: Adenoid Cystic Carcinoma
Interventions: Radiation: Radiation;   Drug: Pembrolizumab
14 Not yet recruiting Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: TACE and Apatinib;   Procedure: TACE
15 Recruiting SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: SBRT
16 Recruiting A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Conditions: Advanced Adult Hepatocellular Carcinoma;   Advanced Fibrolamellar Carcinoma
Intervention: Drug: ENMD-2076
17 Recruiting Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: CF102;   Drug: Placebo
18 Not yet recruiting A Study of DC-CIK to Treat Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC)
Intervention: Biological: Dendritic and Cytokine-induced Killer Cells
19 Not yet recruiting Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Milciclib maleate
20 Not yet recruiting Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
Condition: Hepatocellular Carcinoma
Interventions: Genetic: GLYCAR T cells;   Drug: Cytoxan;   Drug: Fludarabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.